<?xml version="1.0" encoding="UTF-8"?>
<p id="Par61">
 <italic>PLCG2</italic> mRNA upregulation has been reported in cortical tissue of LOAD patients (FC, 1.35; 
 <italic>p</italic> = 0.0028, [
 <xref ref-type="bibr" rid="CR33">33</xref>]) and in transgenic mice carrying mutations associated with early AD (APP KM670/671 NL, PNSEN1 M146V) or overexpressing the human tau-4R/2N isoform (P301L) [
 <xref ref-type="bibr" rid="CR34">34</xref>, 
 <xref ref-type="bibr" rid="CR35">35</xref>]. However, normalization to microglia-specific genes (e.g., Abi3) and data from single-cell profiling of brain immune cells [
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR36">36</xref>, 
 <xref ref-type="bibr" rid="CR37">37</xref>], suggest that apparent PLCG2 transcript upregulation in bulk tissue is mostly related to microgliosis occurring as a consequence of neurodegeneration.
</p>
